Ulrich M. Caroli

Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases

Peter Radny, Ulrich M. Caroli, Jürgen Bauer et al. · British Journal of Cancer · 2003 · 186 citations · Full text

Medicine, Dermatology, Oncology +17

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma

Thomas Eigentler, Anne Kamin, Benjamin Weide et al. · Journal of the American Academy of Dermatology · 2007 · 93 citations

Medicine, Dermatology, Pharmacotherapy +4

Pimecrolimus cream 1% in erosive oral lichen planus- a prospective randomized double-blind vehicle-controlled study

Thomas Volz, Ulrich M. Caroli, Holger Lüdtke et al. · British Journal of Dermatology · 2008 · 85 citations

Pharmacy, Dermatology, Pharmacotherapy +12

Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly

Emmanuella Guenova, Thomas Volz, Martin Eichner et al. · Allergy · 2010 · 69 citations

Life Sciences, Dermatology, Immunology +17

Fibroblast growth factor‐2 but not Mel‐CAM and/or β3 integrin promotes progression of melanocytes to melanoma

Friedegund Meier, Ulrich M. Caroli, Kapaettu Satyamoorthy et al. · Experimental Dermatology · 2003 · 42 citations

Life Sciences, Cancer Biology, Cell Biology +16